skip to main
|
skip to sidebar
Elocon Pharmacy
elocon, buy elocon
Sunday, 2 November 2008
Statins Show Promise For Blood Clot Prevention
Statins, the class of drugs commonly used for lowering cholesterol, are now showing promise at preventing deep vein thrombosis (DVT) or blood clots, an affliction that occurs in nearly 2 million Americans each year.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Followers
Blog Archive
▼
2008
(87)
▼
November
(25)
FDA Approves Astellas' Vaprisol(R) (Conivaptan Hyd...
Test Shown To Reduce Mortality By 42% For Patients...
Donor Cells For Immune Therapy For Patients With L...
World's First Blood-Based Diagnostic Test For Huma...
Variant CJD And Blood Transfusion
PharmaMar Presents New Data Of Zalypsis(R) And Irv...
Cancer Drug Vidaza(R) Receives Positive Opinion Fr...
GPC Biotech Presents New Pre-Clinical Data On RGB-...
Statins Show Promise For Blood Clot Prevention
Publication On 'Tregitopes' In Blood Journal Of Oc...
Myelodysplastic Syndromes: Vidaza Receives Positve...
New Insight For Treating Vascular Disease
Better Instructions Reduce Complications Among Pat...
The MDS Foundation Supports Vidaza's Recommendatio...
Simple Test To Predict Pre-Eclampsia In Sight
Concert Pharmaceuticals Announces Preclinical Resu...
Advances In The Science And Practice Of Transfusio...
Link Between 'Old Blood' And Infection
Gemin X Pan Bcl-2 Inhibitor Obatoclax Shows Biolog...
Stanford Blood Center To Honor People Who Have Don...
Karo Bio: Successful Phase II Study Expands The Po...
Northfield Laboratories Inc. Announces Submission ...
New Grant For Blood Substitutes
Influence Of Serum Deprivation On Adherence And Pr...
How The Body's Clot-Busting System Speeds Up Ather...
►
October
(38)
►
September
(24)
About Me
lomik
View my complete profile
No comments:
Post a Comment